Tony E. Godfrey, PhD

Professor, Surgery

Tony Godfrey
617.414.8013
700 Albany St Ctr for Adv Biomed Res

Biography

Tony E. Godfrey, PhD, Associate Chair, Surgical Research and Associate Professor of Surgery, Boston University School of Medicine, earned a bachelor’s of science degree in biochemistry from Brunel University in England, followed by a doctorate in molecular biology and biochemistry, also from Brunel. He attended the University of California, San Francisco, for postdoctoral fellowships and managed UCSF’s Genome Analysis Core Facility.

Most recently, Dr. Godfrey was a Research Associate Professor in the Department of Surgery at the University of Rochester Medical Center in Rochester, NY. Prior to this he was an Associate Professor of Pathology at Mt. Sinai School of Medicine in New York, NY.

Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s esophagus and esophageal adenocarcinoma; a tumor with rapidly increasing incidence in the United States and other western countries. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.

Other Positions

  • Professor, Computational Biomedicine, Medicine, Boston University School of Medicine
  • Member, BU-BMC Cancer Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
  • Member, Genome Science Institute, Boston University

Education

  • Brunel University, PhD
  • Brunel University, BSc

Classes Taught

  • GMSMM703

Publications

  • Published on 3/10/2021

    Godfrey TE, Litle VR. Commentary: For thoracic surgeons, a strategic approach to the funding game. J Thorac Cardiovasc Surg. 2021 Mar 10. PMID: 33812681.

    Read at: PubMed
  • Published on 6/18/2019

    Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A. Corrigendum to "Considerations and quality controls when analyzing cell-free tumor DNA" [Biomol. Detect. Quantif. 17 (2019) 100078]. Biomol Detect Quantif. 2019 Mar; 17:100091. PMID: 31249790.

    Read at: PubMed
  • Published on 6/1/2019

    Pennathur A, Godfrey TE, Luketich JD. The Molecular Biologic Basis of Esophageal and Gastric Cancers. Surg Clin North Am. 2019 Jun; 99(3):403-418. PMID: 31047032.

    Read at: PubMed
  • Published on 5/15/2019

    Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L. Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma. Clin Exp Gastroenterol. 2019; 12:219-229. PMID: 31190949.

    Read at: PubMed
  • Published on 5/3/2019

    Egyud M, Tejani M, Pennathur A, Luketich J, Sridhar P, Yamada E, Ståhlberg A, Filges S, Krzyzanowski P, Jackson J, Kalatskaya I, Jiao W, Nielsen G, Zhou Z, Litle V, Stein L, Godfrey T. Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma. Ann Thorac Surg. 2019 08; 108(2):343-349. PMID: 31059681.

    Read at: PubMed
  • Published on 5/2/2019

    He HJ, Stein EV, Konigshofer Y, Forbes T, Tomson FL, Garlick R, Yamada E, Godfrey T, Abe T, Tamura K, Borges M, Goggins M, Elmore S, Gulley ML, Larson JL, Ringel L, Haynes BC, Karlovich C, Williams PM, Garnett A, Ståhlberg A, Filges S, Sorbara L, Young MR, Srivastava S, Cole KD. Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements. J Mol Diagn. 2019 07; 21(4):658-676. PMID: 31055023.

    Read at: PubMed
  • Published on 3/5/2019

    Filges S, Yamada E, Ståhlberg A, Godfrey TE. Impact of Polymerase Fidelity on Background Error Rates in Next-Generation Sequencing with Unique Molecular Identifiers/Barcodes. Sci Rep. 2019 03 05; 9(1):3503. PMID: 30837525.

    Read at: PubMed
  • Published on 2/13/2019

    Johansson G, Andersson D, Filges S, Li J, Muth A, Godfrey TE, Ståhlberg A. Considerations and quality controls when analyzing cell-free tumor DNA. Biomol Detect Quantif. 2019 Mar; 17:100078. PMID: 30906693.

    Read at: PubMed
  • Published on 12/15/2018

    Egyud M, Sridhar P, Devaiah A, Yamada E, Saunders S, Ståhlberg A, Filges S, Krzyzanowski PM, Kalatskaya I, Jiao W, Stein LD, Jalisi S, Godfrey TE. Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer. Head Neck. 2019 05; 41(5):1351-1358. PMID: 30554450.

    Read at: PubMed
  • Published on 4/12/2017

    Muñoz-Largacha JA, Gower AC, Sridhar P, Deshpande A, O'Hara CJ, Yamada E, Godfrey TE, Fernando HC, Litle VR. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma. J Thorac Cardiovasc Surg. 2017 08; 154(2):714-727. PMID: 28495058.

    Read at: PubMed

View 75 more publications: View full profile at BUMC

View all profiles